Literature DB >> 19356729

Celastrol binds to ERK and inhibits FcepsilonRI signaling to exert an anti-allergic effect.

Youngmi Kim1, Kyungjong Kim, Hansoo Lee, Sanghwa Han, Yun-Sil Lee, Jongseon Choe, Young-Myeong Kim, Jang-Hee Hahn, Jai Youl Ro, Dooil Jeoung.   

Abstract

The role of celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," in allergic inflammation was investigated. Celastrol decreased the secretion of beta-hexosaminidase, decreased the release of histamine, decreased the expression of Th2 cytokines and decreased calcium influx and cell adhesion in antigen-stimulated RBL2H3 cells. Exposure to celastrol decreased the phosphorylation of extracellular regulated kinase (ERK) and the ERK kinase activity was decreased in RBL2H3 cells. A molecular dynamics simulation showed binding of celastrol to a large pocket in ERK2, which serves as the ATP-binding site. Exposure to celastrol inhibited the interaction between immunoglobulin Fc epsilon receptor I (FcepsilonRIgamma) and ERK and inhibited interaction between FcepsilonRIgamma and protein kinase C delta (PKCdelta). Antigen stimulation induced an interaction between Rac1 and ERK as well as an interaction between Rac1 and PKCdelta. Inhibition of ERK decreased Rac1 activity and inhibition of Rac1 decreased ERK activity in antigen-stimulated RBL2H3 cells. Celastrol regulated the expression of epithelial-mesenchymal transition (EMT)-related proteins through inhibition of PKCalpha, PKCdelta, and Rac1 in antigen-stimulated RBL2H3 cells. Exposure to celatrol inhibited PKCdelta activity in antigen-stimulated RBL2H3 cells. Celastrol exerted a negative effect on FcepsilonRIbeta signaling by inhibiting the interaction between heat shock protein 90 (hsp90) and proteins, such as, FcepsilonRIbeta, Akt and PKCalpha. Celastrol exerted a negative effect on in vivo atopic dermatitis induced by 2, 4-dinitrofluorobenzene (DNFB), which requires ERK. Celastrol also showed an inhibitory effect on skin inflammation induced by phorbol myristate acetate (PMA) in Balb/c mice. In summary, celastrol binds to ERK and inhibits FcepsilonRI signaling to exert an anti-inflammatory effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19356729     DOI: 10.1016/j.ejphar.2009.03.071

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  18 in total

1.  Celastrol prevents cadmium-induced neuronal cell death via targeting JNK and PTEN-Akt/mTOR network.

Authors:  Sujuan Chen; Chenjian Gu; Chong Xu; Jinfei Zhang; Yijiao Xu; Qian Ren; Min Guo; Shile Huang; Long Chen
Journal:  J Neurochem       Date:  2013-10-24       Impact factor: 5.372

2.  Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose- and cell type-dependent way.

Authors:  Denghai Zhang; Limin Xu; Fanfan Cao; Tingxuan Wei; Chunxin Yang; Georges Uzan; Bin Peng
Journal:  Cell Stress Chaperones       Date:  2010-05-18       Impact factor: 3.667

3.  Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells.

Authors:  Gayathri Chadalapaka; Indira Jutooru; Stephen Safe
Journal:  Carcinogenesis       Date:  2012-02-14       Impact factor: 4.944

4.  Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors.

Authors:  Bokyung Sung; Byoungduck Park; Vivek R Yadav; Bharat B Aggarwal
Journal:  J Biol Chem       Date:  2010-02-12       Impact factor: 5.157

5.  NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action.

Authors:  Vincent Jaquet; Julien Marcoux; Eric Forest; Kevin G Leidal; Sally McCormick; Yvonne Westermaier; Remo Perozzo; Olivier Plastre; Laetitia Fioraso-Cartier; Becky Diebold; Leonardo Scapozza; William M Nauseef; Franck Fieschi; Karl-Heinz Krause; Karen Bedard
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

6.  Celastrus-derived celastrol suppresses autoimmune arthritis by modulating antigen-induced cellular and humoral effector responses.

Authors:  Shivaprasad H Venkatesha; Hua Yu; Rajesh Rajaiah; Li Tong; Kamal D Moudgil
Journal:  J Biol Chem       Date:  2011-03-14       Impact factor: 5.157

7.  HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way.

Authors:  Bin Peng; Limin Xu; Fanfan Cao; Tingxuan Wei; Chunxin Yang; Georges Uzan; Denghai Zhang
Journal:  Mol Cancer       Date:  2010-04-16       Impact factor: 27.401

8.  Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease.

Authors:  Daniel Paris; Nowell J Ganey; Vincent Laporte; Nikunj S Patel; David Beaulieu-Abdelahad; Corbin Bachmeier; Amelia March; Ghania Ait-Ghezala; Michael J Mullan
Journal:  J Neuroinflammation       Date:  2010-03-08       Impact factor: 8.322

9.  Celastrol and Its Role in Controlling Chronic Diseases.

Authors:  Shivaprasad H Venkatesha; Kamal D Moudgil
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 10.  NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS.

Authors:  Eugenia Cifuentes-Pagano; Gabor Csanyi; Patrick J Pagano
Journal:  Cell Mol Life Sci       Date:  2012-05-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.